Montserrat Sierra Colomina

Dr. Montserrat Sierra Colomina

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PDF file
MCMontserrat Sierra Colomina
Montserrat Sierra Colomina
AFAlix Flamant
Alix Flamant
GBGuillaume Le Balle
Guillaume Le Balle
JCJérémie F. Cohen
Jérémie F. Cohen
LBLionel Berthomieu
Lionel Berthomieu
CBCamille Brehin
Camille Brehin
We found a high respiratory infection rate, frequent procedural interventions, 3.5% fatality, and predominance of emm1/emm12 genotypes.

27 August 2020 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
MCMontserrat Sierra Colomina
Montserrat Sierra Colomina
AGAlberto García-Salido
Alberto García-Salido
ILInés Leoz‐Gordillo
Inés Leoz‐Gordillo
AAAmelia Martínez de Azagra‐Garde
Amelia Martínez de Azagra‐Garde
GMGustavo Melen
Gustavo Melen
ASAna Serrano‐González
Ana Serrano‐González

20 June 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
MCMontserrat Sierra Colomina
Montserrat Sierra Colomina
NYNagam Anna Yehia
Nagam Anna Yehia
FMFarhan Mahmood
Farhan Mahmood
CPChris Parshuram
Chris Parshuram
HMHaifa Mtaweh
Haifa Mtaweh
The utilization of noninvasive ventilation (NIV) in pediatric intensive care units (PICUs), to support children with respiratory failure and avoid endotracheal intubation, has increased. Current guidelines recommend initiating enteral nutrition (EN) within the first 24–48 h post admission. This practice remains variable among PICUs due to perceptions of a lack of safety data and the potential increase in respiratory and gastric complications. The objective of this retrospective study was to evaluate the association between EN and development of extraintestinal complications in children 0–18 years of age on NIV for acute respiratory failure. Of 332 patients supported with NIV, 249 (75%) were enterally fed within the first 48 h of admission. Respiratory complications occurred in 132 (40%) of the total cohort and predominantly in non-enterally fed patients (60/83, 72% vs. 72/249, 29%; p < 0.01), and they occurred earlier during ICU admission (0 vs. 2 days; p < 0.01). The majority of complications were changes in the fraction of inspired oxygen (220/290, 76%). In the multivariate evaluation, children on bilevel positive airway pressure (BiPAP) (23/132, 17% vs. 96/200, 48%; odds ratio [OR] = 5.3; p < 0.01), receiving a higher fraction of inspired oxygen (FiO2) (0.42 vs. 0.35; OR = 6; p = 0.03), and with lower oxygen saturation (SpO2) (91% vs. 97%; OR = 0.8; p < 0.01) were more likely to develop a complication. Time to discharge from the intensive care unit (ICU) was longer for patients with complications (11 vs. 3 days; OR = 1.12; p < 0.01). The large majority of patients requiring NIV can be enterally fed without an increase in respiratory complications after an initial period of ICU stabilization.

23 June 2025 in Journal of Human Immunity
Verified
Journal Article
Open access
SBSimon Boutinaud
Simon Boutinaud
VBVincent Barlogis
Vincent Barlogis
LBLionel Berthomieu
Lionel Berthomieu
MCMontserrat Sierra Colomina
Montserrat Sierra Colomina
MPMarlène Pasquet
Marlène Pasquet
A 6-month-old infant with Omenn syndrome and severe hypertrophic cardiomyopathy showed significant clinical improvement following multimodal immunosuppression with anti–IL-5 and alemtuzumab. This targeted approach successfully stabilized the patient, providing a critical bridge to curative hematopoietic stem cell transplantation.